244 related articles for article (PubMed ID: 17296744)
21. Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1).
Yun NE; Linde NS; Zacks MA; Barr IG; Hurt AC; Smith JN; Dziuba N; Holbrook MR; Zhang L; Kilpatrick JM; Arnold CS; Paessler S
Virology; 2008 Apr; 374(1):198-209. PubMed ID: 18234269
[TBL] [Abstract][Full Text] [Related]
22. Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam.
Le MT; Wertheim HF; Nguyen HD; Taylor W; Hoang PV; Vuong CD; Nguyen HL; Nguyen HH; Nguyen TQ; Nguyen TV; Van TD; Ngoc BT; Bui TN; Nguyen BG; Nguyen LT; Luong ST; Phan PH; Pham HV; Nguyen T; Fox A; Nguyen CV; Do HQ; Crusat M; Farrar J; Nguyen HT; de Jong MD; Horby P
PLoS One; 2008 Oct; 3(10):e3339. PubMed ID: 18836532
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of a specific polyclonal equine F(ab')2 against avian influenza (H5N1) in ferrets: synergy with oseltamivir.
Herbreteau CH; Denizot M; Lowther S; Riddell S; Frazer L; Haining J; Arkinstall R; Payne J; Harper J; Johnson D; Pasquier A; Middleton D; Saluzzo JF
Immunotherapy; 2016 Sep; 8(9):1021-32. PubMed ID: 27380317
[TBL] [Abstract][Full Text] [Related]
24. Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice.
Smee DF; Hurst BL; Wong MH; Bailey KW; Morrey JD
Antimicrob Agents Chemother; 2009 May; 53(5):2120-8. PubMed ID: 19273672
[TBL] [Abstract][Full Text] [Related]
25. Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design.
Reddy MB; Yang KH; Rao G; Rayner CR; Nie J; Pamulapati C; Marathe BM; Forrest A; Govorkova EA
PLoS One; 2015; 10(10):e0138069. PubMed ID: 26460484
[TBL] [Abstract][Full Text] [Related]
26. Natural Reassortants of Potentially Zoonotic Avian Influenza Viruses H5N1 and H9N2 from Egypt Display Distinct Pathogenic Phenotypes in Experimentally Infected Chickens and Ferrets.
Naguib MM; Ulrich R; Kasbohm E; Eng CLP; Hoffmann D; Grund C; Beer M; Harder TC
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931674
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the efficacy of a pre-pandemic H5N1 vaccine (MG1109) in mouse and ferret models.
Song MS; Moon HJ; Kwon HI; Pascua PN; Lee JH; Baek YH; Woo GJ; Choi J; Lee S; Yoo H; Oh I; Yoon Y; Rho JB; Sung MH; Hong SP; Kim CJ; Choi YK
J Microbiol; 2012 Jun; 50(3):478-88. PubMed ID: 22752912
[TBL] [Abstract][Full Text] [Related]
28. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
[TBL] [Abstract][Full Text] [Related]
29. Neuraminidase amino acids 149 and 347 determine the infectivity and oseltamivir sensitivity of pandemic influenza A/H1N1 (2009) and avian influenza A/H5N1.
Yongkiettrakul S; Nivitchanyong T; Pannengpetch S; Wanitchang A; Jongkaewwattana A; Srimanote P
Virus Res; 2013 Aug; 175(2):128-33. PubMed ID: 23639424
[TBL] [Abstract][Full Text] [Related]
30. Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
Smith GE; Sun X; Bai Y; Liu YV; Massare MJ; Pearce MB; Belser JA; Maines TR; Creager HM; Glenn GM; Flyer D; Pushko P; Levine MZ; Tumpey TM
Virology; 2017 Sep; 509():90-97. PubMed ID: 28624679
[TBL] [Abstract][Full Text] [Related]
31. Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility.
McKimm-Breschkin JL; Barrett S; Wong FYK; Pudjiatmoko ; Azhar M; Selleck P; Davies KR; Hartaningsih N; McGrane J
Antiviral Res; 2018 May; 153():95-100. PubMed ID: 29574145
[TBL] [Abstract][Full Text] [Related]
32. Assessing the susceptibility of highly pathogenic avian influenza H5N1 viruses to oseltamivir using embryonated chicken eggs.
Tare DS; Kode SS; Hurt AC; Pawar SD
Indian J Med Res; 2019 Nov; 150(5):486-491. PubMed ID: 31939392
[TBL] [Abstract][Full Text] [Related]
33. Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets.
Forrest HL; Khalenkov AM; Govorkova EA; Kim JK; Del Giudice G; Webster RG
Vaccine; 2009 Jun; 27(31):4187-95. PubMed ID: 19406182
[TBL] [Abstract][Full Text] [Related]
34. T-705 (favipiravir) activity against lethal H5N1 influenza A viruses.
Kiso M; Takahashi K; Sakai-Tagawa Y; Shinya K; Sakabe S; Le QM; Ozawa M; Furuta Y; Kawaoka Y
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):882-7. PubMed ID: 20080770
[TBL] [Abstract][Full Text] [Related]
35. Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.
Tilmanis D; Koszalka P; Barr IG; Rossignol JF; Mifsud E; Hurt AC
Antiviral Res; 2020 Aug; 180():104851. PubMed ID: 32544408
[TBL] [Abstract][Full Text] [Related]
36. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
[TBL] [Abstract][Full Text] [Related]
37. Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection.
Cho J; Yi H; Jang EY; Lee MS; Lee JY; Kang C; Lee CH; Kim K
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):298-304. PubMed ID: 29017920
[TBL] [Abstract][Full Text] [Related]
38. Inefficient transmission of H5N1 influenza viruses in a ferret contact model.
Yen HL; Lipatov AS; Ilyushina NA; Govorkova EA; Franks J; Yilmaz N; Douglas A; Hay A; Krauss S; Rehg JE; Hoffmann E; Webster RG
J Virol; 2007 Jul; 81(13):6890-8. PubMed ID: 17459930
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.
Kumaki Y; Day CW; Smee DF; Morrey JD; Barnard DL
Antiviral Res; 2011 Nov; 92(2):329-40. PubMed ID: 21925541
[TBL] [Abstract][Full Text] [Related]
40. Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.
Marriott AC; Dove BK; Whittaker CJ; Bruce C; Ryan KA; Bean TJ; Rayner E; Pearson G; Taylor I; Dowall S; Plank J; Newman E; Barclay WS; Dimmock NJ; Easton AJ; Hallis B; Silman NJ; Carroll MW
PLoS One; 2014; 9(4):e94090. PubMed ID: 24709834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
